Previously, a meta-analysis based on 29400 patients with 116000 controls from 63 studies found BRIP1 was associated with a high risk of ovarian cancer and the HRR pathway might be involved [27, 28]. The gene discussed is BRIP1; the disease is ovarian carcinoma.